Atlas Trials

Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)

Clinical trial NCT05784142 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05784142
Sponsor
Jiangsu Cancer Institute & Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer, Non-small Cell
Start date
2022-10-27
Primary completion
2024-12-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.